The observed anti-inflammatory effect in WAT and lowered circulating leptin levels in the current study could therefore also indirectly have contributed to the attenuation of hepatic inflammation and liver fibrosis with BU. The gene discussed is LEP; the disease is Hepatic fibrosis.